A quantum dots and superparamagnetic nanoparticle-based method for the detection of HPV DNA
© Yu-Hong et al; licensee Springer. 2011
Received: 21 March 2011
Accepted: 20 July 2011
Published: 20 July 2011
The recent advance in nanomaterial research field prompts the development of diagnostics of infectious diseases greatly. Many nanomaterials have been developed and applied to molecular diagnostics in labs. At present, the diagnostic test of human papillomavirus (HPV) relies exclusively on molecular test. Hereon, we report a rapid and facile quantum dots (QDs) and superparamagnetic nanoparticle-based hybridization assay for the detection of (HPV) 16 infections which combines the merits of superparamagnetic nanoparticles and QDs and wholly differs from a conventional hybridization assay at that the reaction occurs at homogeneous solution, and total time for detection is no more than 1 h.
The probes were labeled with superparamagnetic nanoparticles and QDs. Sixty cervical swab samples were used to perform a hybridization assay with these probes, and the results were compared with type-specific polymerase chain reaction (PCR) method.
The statistic analysis suggests that there is no significant difference between these two methods. Furthermore, this method is much quicker and easier than the type-specific PCR method.
This study has successfully validated the clinical performance of our hybridization assay. The advantages in the time of detection and ease of process endow this method with great potential in clinical usage, especially mass epidemiological screening.
KeywordsHPV DNA quantum dots superparamagnetic nanoparticles hybridization cervical cancer
Human papillomavirus (HPV) is a small non-enveloped DNA virus that merely infects human squamous epithelial cells. Its genome is a double-stranded circular DNA molecule of 8,000 base pairs (bp) which is divided into three parts, including a segment of about 4,000 bp that encodes proteins mainly involved in viral DNA replication and cell transformation, a segment of about 3,000 bp that encodes the structural proteins of the virus particles as well as a segment of about 1,000 bp that contains the origin of viral DNA replication and transcriptional regulatory elements [1, 2]. HPVs can cause a large spectrum of epithelial lesions, primarily benign hyperplasia with low malignant potential such as warts, papillomas, and so forth. Based on epidemiological and molecular evidence, HPV types 16 and 18 were recognized as the high-risk types that were carcinogenic in humans [2, 3]. HPV-16 accounts for approximately 50% of all cervical cancers, while HPV-18 is the next most common type and typically is found in from 15% to 20% of squamous cell cancers and in a greater proportion of adenocarcinomas [2–6]. However, cervical cancer is a highly preventable disease when early screening programs are employed that facilitate the detection and treatment of precancerous lesions. Assisted by early detection, the 5-year survival rate for the earliest stage of invasive cervical cancer can be fairly high [7, 8].
In recent years, various nanomaterials have been applied to the field of molecular diagnostics [9, 10]. Quantum dots (QDs), one of these nanomaterials, are nearly spherical semiconductor particles with diameters from 2 to 10 nm, comprising 200 to 10,000 atoms. QDs have size-controlled luminescence functions, which mean the same material with variable sizes can exhibit different colors under the excitation of an appropriate wavelength; broad absorption spectra; and narrow emission spectra, which mean simultaneous excitation of different colored QDs by a single wavelength [11, 12]. In addition, QDs are extremely photostable and highly resistant to photobleaching, which has been reported to be more photostable than a number of organic dyes, including the most stable organic dye, Alexa 488 [13, 14]. With their rapid progress, various QDs-bioconjugates have been developed for imaging, labeling, and sensing . Manipulable superparamagnetic nanoparticle through contrived magnetic field is another outstanding nanomaterial, which has been applied to magnetic resonance imaging contrast enhancement, immunoassay, hyperthermia, magnetic drug delivery, magnetofection, cell separation, or cell labeling . Especially in biological separation and diagnosis, the superparamagnetic nanoparticle has a unique advantage over others.
Herein, we report a novel detection method of HPV DNA combining the advantages of QDs and manipulability of superparamagnetic nanoparticles and validate it clinically.
Collection of samples
One hundred sixty cervical swab samples were collected from outpatients at our department, and the written informed consent was obtained. Ten HPV-16-negative and ten HPV-16-positive human DNA samples were kept in the clinical laboratory of our department. QIAamp® DNA Blood Mini Kits (Qiagen) were used to extract DNA according to the manufacturer's protocol. All DNA samples were eluted with the same volume and then frozen in -70°C until further analysis after quantitated with UV spectrometer (Beckman Coulter, Inc., Beijing, People's Republic of China).
Preparation of CdTe QD-labeled DNA probes
Hybridization probes and type-specific PCR primers
Type-specific PCR upper primer
TGT GCT GCC ATA TCT ACT TCA GAA ACT AC
Type-specific PCR lower primer
TAG ACC AAA ATT CCA GTC CTC CAA A
Preparation of superparamagnetic nanoparticle
The superparamagnetic nanoparticles were synthesized according to Nagao et al. with slight modification . Briefly, 5 mL of 2-M FeCl2 and 20 mL of 1-M FeCl3 were mixed in 212 mL of Milli-Q water that had been bubbled with nitrogen for 30 min. Fe3O4 nanoparticles were chemically co-precipitated by adding 12 mL of NH3 solution at room temperature under continuous mixing and washed four times in water and several times in ethanol. During washing, the superparamagnetic Fe3O4 nanoparticles were separated with a NdFeB magnet, and the particles were finally dried in a vacuum oven at 70°C. The transmission electron microscopy (JEOL, Tokyo, Japan) was used to characterize the size of the magnetic nanoparticles. XRD was used to confirm the crystalline phase of superparamagnetic nanoparticles.
Modification and coupling of superparamagnetic nanoparticle
3-Aminopropyl-trimethoxysilane (APTMS) modification and coupling process of superparamagnetic nanoparticles were prepared according to the method described by Kouassi et al. . One gram of Fe3O4 nanoparticles were washed with methanol and Milli-Q water and then added to 10 mL of 3 mM APTMS in a toluene/methanol with a ratio of 1:1 in volume in a three-necked flask with a condenser and temperature controller protected by N2 at 80°C for 20 h under vigorous stirring. Amino group-modified Fe3O4 nanoparticles were separated by a NdFeB magnet and washed several times with methanol and Milli-Q water alternately and then dried at 50°C in a vacuum oven. Approximately 50 mg of APTMS-modified Fe3O4 nanoparticles was added into 10 mL of 0.05 mg/mL of EDAC and sonicated for 25 min at 4°C. After being separated with a NdFeB magnet, 50 nmol of streptavidin in a phosphate buffer solution was added. The resultant mixture was sonicated for 1 h, and the particles coupled with streptavidin were magnetically extracted. SDS-PAGE was used to verify the conjugation of the superparamagnetic nanoparticles and probes.
Determine of cutoff value and validation of QDs and superparamagnetic nanoparticle-based hybridization
Detection of HPV-16 with QDs and superparamagnetic nanoparticle-based hybridization
The rationale of QDs and superparamagnetic nanoparticle-based hybridization is illustrated in Figure 1. A 0.05-μg biotin-labeled capture probes and QD-labeled detective probes described by Lee et al.  (Table 1) were mixed adequately with 2 μL of DNA samples in a volume with a total of 100-μL-long oligo hybridization solution (Corning Incorporated, Shanghai, China) and predenatured at 95°C for 10 min, then 55°C for 30 min. The particles coupled with streptavidin were added into the hybridization mixtures and incubated at 37°C for 10 min and enriched in the bottom of the tube with a NdFeB magnet. A 20-μL supernatant was taken to measure relative fluorescence intensity by LS 55 luminescence spectrometer (Perkin-Elmer, Beijing, China).
Detection of HPV16 with type-specific PCR
The 160 DNA samples were also analyzed with type-specific polymerase chain reaction (PCR) according to Lin et al.  (Table 1). The PCR reaction system consisted of 3 μL DNA sample, 15 mM Tris-HCl (pH 8.0), 2.5 mM MgCl2, 50 mM KCl, 0.25 mM dNTPs, 10 μM upper and lower primers, and 0.5 U of Hot-Start Taq DNA polymerase (Takara, Otsu, Shiga, Japan). The PCR reaction mixture was preheated for 5 min at 94°C, followed by 45 cycles of 30 s at 94°C, 30 s at 59°C, 30 s at 72°C, and a final extension of 5 min at 72°C. A no-template reaction was implemented in each assay as negative control, and each sample was performed in triplicate. PCR products were analyzed in 1% agarose gel electrophoresis.
The comparison between QDs and superparamagnetic nanoparticle-based hybridization and type-specific PCR was analysized by the Statistics Package for Social Sciences (SPSS) software. A p value above 0.05 was considered that there was no significant difference between the two methods.
Characterization of quantum dots
Characterization of superparamagnetic nanoparticles
The cutoff value of QDs and superparamagnetic nanoparticle-based hybridization
Ten HPV-16-negtive samples were repeated three times with the abovementioned method; the means were used to determine the cutoff value. According to the data, the cutoff value of this assay was defined as 14.5, any result under 14.5 from the 160 DNA samples was considered as positive one (Figure 3). Based on this cutoff value, all of the ten HPV-16-positve DNA samples were determined as positive results.
Comparison of QDs and superparamagnetic nanoparticle-based hybridization with type-specific PCR
Comparison between QDs and superparamagnetic nanoparticle-based hybridization and type-specific PCR
In this paper, we have successfully developed a novel and facile hybridization for the qualitative detection of HPV-16 in cervical swab samples. Compared with type-specific PCR, the greatest advantages of our QDs and superparamagnetic nanoparticle-based hybridization consists in the time of detection and ease of process. Generally speaking, type-specific PCR for detection of HPV-16 DNA takes a skillful laboratory assistant about 4 h, while our hybridization assays only need no more than 1 h. In addition, a typical type-specific PCR assay consists of the extraction of DNA of cervical swab samples, PCR reaction and nucleic acid agarose gel electrophoresis and staining of ethidium bromide, while our hybridization assay method only require extraction of DNA of the samples and simple incubation as well as magnetic separation, which has a good acceptability for any average lab assistant.
With the increasing interest in the development of diverse nanomaterials, many researchers all over the world are pushing the envelope to expand the application of those versatile materials in the field of medicine. Up to the present, numerous nanomaterials have been applied to diagnose infectious diseases such as human immunodeficiency virus, respiratory syncytial virus, hepatitis B virus, hepatitis C virus (HCV), hepatitis E virus, herpes simplex virus, and so forth [23–28]. Surely, nanotechnology brings new opportunities in diagnostics which allows for the diagnosis of infectious diseases in a sensitive, specific, and rapid format at lower costs than current in-use technologies. As declared by Jain KK, applications of nanotechnology are beginning to show an impact on the practice of conventional medicine; it is bound to continue as hotspot of research for next several decades .
In conclusion, we showed a rapid and facile hybridization method for the qualitative detection of HPV-16 DNA in cervical swab samples and successfully validated it in 160 clinical samples. It differs from conventional hybridization assays in such a way that the reaction occurs at homogeneous solution and that of conventional hybridization assay bases on the solid supporter such as polyvinylidene fluoride membrane or nitrocellulose membrane. Therefore, this method has great potential in clinical usage, especially mass epidemiological screening.
- Münger K, Baldwin A, Edrwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K: Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004, 78: 11451–11460. 10.1128/JVI.78.21.11451-11460.2004View ArticleGoogle Scholar
- Psyrri A, DiMaio D: Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol 2008, 5: 24–31.View ArticleGoogle Scholar
- Stanley MA, Pett MR, Coleman N: HPV: from infection to cancer. Biochem Soc Trans 2007, 35: 1456–1460. 10.1042/BST0351456View ArticleGoogle Scholar
- zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2: 342–350. 10.1038/nrc798View ArticleGoogle Scholar
- Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118: 3030–3044. 10.1002/ijc.21731View ArticleGoogle Scholar
- Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M: Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 2008, 113: 1980–1993. 10.1002/cncr.23704View ArticleGoogle Scholar
- Ginocchio CC, Barth D, Zhang F: Comparison of the third wave invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA. J Clin Microbiol 2008, 46: 1641–1646. 10.1128/JCM.01824-07View ArticleGoogle Scholar
- Denny LA, Wright TC Jr: Human papillomavirus testing and screening. Best Pract Res Clin Obstet Gynaecol 2005, 19: 501–515. 10.1016/j.bpobgyn.2005.02.004View ArticleGoogle Scholar
- Alivisatos P: The use of nanocrystals in biological detection. Nat Biotechnol 2004, 22: 47–52. 10.1038/nbt927View ArticleGoogle Scholar
- Rosi NL, Mirkin CA: Nanostructures in biodiagnostics. Chem Rev 2005, 105: 1547–1562. 10.1021/cr030067fView ArticleGoogle Scholar
- Han M, Gao X, Su JZ, Nie S: Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 2001, 19: 631–635. 10.1038/90228View ArticleGoogle Scholar
- Gill R, Zayats M, Willner I: Semiconductor quantum dots for bioanalysis. Angew Chem Int Ed Engl 2008, 47: 7602–7625. 10.1002/anie.200800169View ArticleGoogle Scholar
- Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F, Bruchez MP: Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003, 21: 41–46. 10.1038/nbt764View ArticleGoogle Scholar
- Huo Q: A perspective on bioconjugated nanoparticles and quantum dots. Colloids Surf B Biointerfaces 2007, 59: 1–10. 10.1016/j.colsurfb.2007.04.019View ArticleGoogle Scholar
- Medintz IL, Uyeda HT, Goldman ER, Mattoussi H: Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005, 4: 435–446. 10.1038/nmat1390View ArticleGoogle Scholar
- Ma HL, Qi XR, Maitani Y, Nagai T: Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm 2007, 333: 177–186. 10.1016/j.ijpharm.2006.10.006View ArticleGoogle Scholar
- Gao MY, Kirstein S, Möhwald H, Rogach AL, Kornowski A, Eychmüller A, Weller H: Strongly photoluminescent CdTe nanocrystals by proper surface modification. J Phys Chem B 1998, 102: 8360–8363. 10.1021/jp9823603View ArticleGoogle Scholar
- Zhao D, Jimei Z, Quanxi D, Ning G, Shichao XU, Bo S, Yuehua BU: Adaption of Au nanoparticles and CdTe quantum dots in DNA detection. Chin J Chem Eng 2007, 15: 791–794. 10.1016/S1004-9541(08)60004-XView ArticleGoogle Scholar
- Lee JY, Li J, Yeung ES: Single-molecule detection of surface-hybridized human papilloma virus DNA for quantitative clinical screening. Anal Chem 2007, 79: 8083–8089. 10.1021/ac071159yView ArticleGoogle Scholar
- Nagao D, Yokoyama M, Yamauchi N, Matsumoto H, Kobayashi Y, Konno M: Synthesis of highly monodisperse particles composed of a magnetic core and fluorescent shell. Langmuir 2008, 24: 9804–9808. 10.1021/la801364wView ArticleGoogle Scholar
- Kouassi GK, Irudayaraj J: Magnetic and gold-coated magnetic nanoparticles as a DNA sensor. Anal Chem 2006, 78: 3234–3241. 10.1021/ac051621jView ArticleGoogle Scholar
- Lin CY, Chao A, Yang YC, Chou HH, Ho CM, Lin RW, Chang TC, Chiou JY, Chao FY, Wang KL, Chien TY, Hsueh S, Huang CC, Chen CJ, Lai CH: Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 2008, 42: 361–367. 10.1016/j.jcv.2008.03.018View ArticleGoogle Scholar
- Tang S, Zhao J, Storhoff JJ, Norris PJ, Little RF, Yarchoan R, Stramer SL, Patno T, Domanus M, Dhar A, Mirkin CA, Hewlett IK: Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 Capsid (p24) antigen. J Acquir Immune Defic Syndr 2007, 46: 231–237. 10.1097/QAI.0b013e31814a554bView ArticleGoogle Scholar
- Tripp RA, Alvarez R, Anderson B, Jones L, Weeks C, Chen W: Bioconjugated nanoparticle detection of respiratory syncytial virus infection. Int J Nanomedicine 2007, 2: 117–124. 10.2147/nano.2007.2.1.117View ArticleGoogle Scholar
- Wang YF, Pang DW, Zhang ZL, Zheng HZ, Cao JP, Shen JT: Visual gene diagnosis of HBV and HCV based on nanoparticle probe amplification and silver staining enhancement. J Med Virol 2003, 70: 205–211. 10.1002/jmv.10379View ArticleGoogle Scholar
- Duan L, Wang Y, Li SS, Wan Z, Zhai J: Rapid and simultaneous detection of human hepatitis B virus and hepatitis C virus antibodies based on a protein chip assay using nano-gold immunological amplification and silver staining method. BMC Infect Dis 2005, 5: 53. 10.1186/1471-2334-5-53View ArticleGoogle Scholar
- Liu HH, Cao X, Yang Y, Liu MG, Wang YF: Array-based nano-amplification technique was applied in detection of hepatitis E virus. J Biochem Mol Biol 2006, 39: 247–252. 10.5483/BMBRep.2006.39.3.247View ArticleGoogle Scholar
- Jain KK: Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta 2005, 358: 37–54. 10.1016/j.cccn.2005.03.014View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.